InsiderTrades

Form 4 for MET MetLife

Accepted 2024-02-29 00:00:00 ET · period of report 2024-02-27 · accession 0001099219-24-000055 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2024-02-29 2024-02-27 MET DEBEL MARLENE EVP, CRO A - Grant — +41.9K 91.5K +85% —
D 2024-02-29 2024-02-27 MET DEBEL MARLENE EVP, CRO F - Tax $69.16 -16.2K 111.2K -13% -$1.12M
D 2024-02-29 2024-02-27 MET DEBEL MARLENE EVP, CRO A - Grant $0.00 +17.9K 17.9K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-02-27 A A 35,957 — 127,454 D — — (F2) Shares acquired from the determination of the performance factor for and payout of 2021-2023 performance share award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan.
2 Common Common Stock 2024-02-27 A A 5,965 — 91,497 D — — (F1) Restricted stock unit award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan.
3 Common Common Stock 2024-02-27 F D 16,206 $69.16 111,248 D — —
4 Derivative Employee Stock Options (right to buy) 2024-02-27 A A 17,896 $0.00 17,896 D $69.16 · — to 2034-02-26 17,896 Common Stock (F4) The options become exercisable in substantially equal installments on each of the first three anniversaries of the grant date.